Second line treatments in advanced platinum-resistant non small cell lung cancer. A critical review of literature. [electronic resource]
Producer: 20090319Description: 27-33 p. digitalISSN:- 1574-8871
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Clinical Trials, Phase III as Topic
- Docetaxel
- Drug Administration Schedule
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Gefitinib
- Glutamates -- administration & dosage
- Guanine -- administration & dosage
- Humans
- Lung Neoplasms -- drug therapy
- Pemetrexed
- Protein Kinase Inhibitors -- administration & dosage
- Quinazolines -- administration & dosage
- Randomized Controlled Trials as Topic
- Taxoids -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.